BioSentinel

Lore & Background

BioSentinel was selected in 2013 and launched on 16 November 2022 as one of ten low-cost CubeSat secondary payloads aboard Artemis 1, the first test flight of NASA's Space Launch System. The spacecraft was deployed in cis-lunar space into an Earth-trailing heliocentric orbit. Its biosensor uses the budding yeast Saccharomyces cerevisiae, with two strains: a wild type proficient in DNA repair and a strain defective in repairing DNA double strand breaks. The yeast's growth and metabolic activity indicate successful DNA repair, measured against onboard radiation sensors and dosimeters.

Reader's Guide

BioSentinel's significance lies in its role as NASA's first mission since Apollo 17 to send living organisms beyond low Earth orbit, directly measuring the biological effects of deep space radiation. By using yeast, which shares DNA repair mechanisms with human cells, the mission provides crucial data on health threats from cosmic rays for long-term human exploration. The mission was extended in August 2023 to November 2024, and again in 2024 by up to 10 months, possibly to September 2025. Two identical payloads—one on the International Space Station and one on Earth—serve as controls to calibrate radiation effects. This work reduces risks for future deep space missions, as no terrestrial laboratory can duplicate the unique space radiation environment.

Did You Know?

• BioSentinel is NASA's first mission to send living organisms beyond low Earth orbit since Apollo 17 in 1972.
• The spacecraft uses two yeast strains: one proficient in DNA repair and one defective in repairing double strand breaks.
• The attitude control thruster assembly is 3D printed in one piece, including propellant tanks, lines, and seven nozzles.
• The mission was extended in 2024 by up to 10 months, possibly to September 2025.

Mission Purpose & the Case for Living Organisms in Deep Space

BioSentinel represents a bold step in astrobiology: sending a living organism beyond low Earth orbit to study how deep space radiation damages and repairs DNA. The spacecraft, a compact CubeSat developed at NASA Ames Research Center, was selected back in 2013 and finally lifted off on 16 November 2022 as one of ten secondary payloads aboard Artemis 1, the inaugural test flight of the Space Launch System. Deployed into cis-lunar space, it became NASA's first mission to carry living organisms past low Earth orbit since Apollo 17 in 1972. The core rationale is straightforward yet urgent: NASA is planning to send humans farther into space than ever before, and no ground-based laboratory can replicate the unique radiation environment encountered beyond Earth's protective magnetic field. By exposing a simple model organism to cosmic rays over an extended period, BioSentinel aims to quantify the biological threat posed by ionizing radiation and ultimately reduce the health risks that would accompany long-duration crewed missions to the Moon, Mars, and beyond.

The Yeast Biosensor: A Window into DNA Repair

At the heart of BioSentinel is a biosensor built around the budding yeast Saccharomyces cerevisiae, chosen for its well-documented flight heritage and, crucially, for the close parallels between its DNA double-strand break repair mechanisms and those found in human cells. Two distinct strains are aboard: a wild-type strain fully capable of repairing radiation-induced damage, and a second strain deliberately defective in mending double-strand breaks, the most harmful type of lesion produced by ionizing radiation. The biosensor pairs these engineered cells with a growth medium containing a metabolic indicator dye, so that visible culture growth and metabolic activity serve as a direct readout of whether DNA repair succeeded. Over the 18-month science phase, multiple sets of wells are wetted at staggered intervals, with a reserve set held in readiness should a solar particle event strike. The total ionizing dose is anticipated to reach roughly four to five krad, and all biological readings are cross-referenced with data from onboard radiation sensors and dosimeters to build a complete picture of how deep space radiation affects living tissue.

Engineering a 6U CubeSat for Deep Space

BioSentinel packs a surprising amount of capability into a 6U CubeSat envelope measuring just 10 by 20 by 30 centimeters and weighing roughly 14 kilograms. Four of its six units are devoted to the science payload, which includes a radiation dosimeter and a dedicated three-color spectrometer for each yeast well. The remaining volume is split among the attitude determination and control subsystem, the electrical power system, and command-and-data-handling avionics. One full unit houses the attitude control thruster assembly, a remarkable piece of engineering: the cold-gas propellant tanks, feed lines, and seven nozzles are 3D printed as a single integrated component, using DuPont R236fa propellant. This additive-manufacturing approach maximizes the 165 grams of stored propellant while keeping each nozzle at 50 millinewtons of thrust and a 31-second specific impulse. The attitude control system is being developed by the Georgia Institute of Technology. Power comes from deployable solar panels rated at 30 watts, and communications rely on an Iris X-band transponder. The spacecraft is a collaborative effort led by NASA Ames, with contributions from JPL, Johnson Space Center, Marshall Space Flight Center, and NASA Headquarters.

Mission Timeline and the Calibration Strategy

Although originally selected in 2013 with a planned 18-month science phase, BioSentinel's operational life has been extended twice. In August 2023, NASA pushed the mission's end date to November 2024, and in 2024 granted a further extension of up to ten months, potentially keeping the spacecraft active as late as September 2025. The science phase itself begins only after the Moon flyby and spacecraft checkout are complete, at which point the first set of yeast-containing wells is wetted with specialized media. To ensure the deep-space data can be properly interpreted, two identical BioSentinel payloads were built as controls: one destined for the International Space Station, where microgravity conditions mirror the spacecraft's but radiation levels are comparatively low, and another kept on Earth's surface, subject to gravity and the protective shielding of the planet's magnetic field. The ISS payload was rehydrated in January 2022, with the ground control following weeks later. Together, these three environments allow researchers to isolate and calibrate the specific biological effects of deep space radiation against analogous measurements taken in lower-radiation settings.